CHOEP regimen: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 7: Line 7:
==Overview==
==Overview==
{{PAGENAME}} refers to an immunochemotherapy regimen consisting of [[cyclophosphamide]], [[Doxorubicin|Doxorubicin(hydroxydaunorubicin)]],  
{{PAGENAME}} refers to an immunochemotherapy regimen consisting of [[cyclophosphamide]], [[Doxorubicin|Doxorubicin(hydroxydaunorubicin)]],  
[[Vincristine|Vincristine (Oncovin)]], [[Etoposide]], [[Prednisone]] of [[non-Hodgkin lymphoma]].<ref>{{Cite web | title = NCI Thesaurus | accessdate =  | url = http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C63452 }}</ref><ref>{{Cite web | title = R-CHOP - National Cancer Institute | accessdate =  | url = http://www.cancer.gov/cancertopics/druginfo/R-CHOP }}</ref>
[[Vincristine|Vincristine (Oncovin)]], [[Prednisone]], [[Etoposide]] of [[non-Hodgkin lymphoma]].<ref>{{Cite web | title = NCI Thesaurus | accessdate =  | url = http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C63452 }}</ref><ref>{{Cite web | title = R-CHOP - National Cancer Institute | accessdate =  | url = http://www.cancer.gov/cancertopics/druginfo/R-CHOP }}</ref>


==Regimen==
==Regimen==
[[Cyclophosphamide|{{button|C Cyclophosphamide}}]]
{{chemo|C|Cyclophosphamide}}


[[Doxorubicin|{{button|H Doxorubicin (Hydroxydaunomycin)}}]]
{{chemo|H|Doxorubicin (Hydroxydaunomycin)}}


[[Vincristine|{{button|O Vincristine (Oncovin)}}]]
{{chemo|O|Vincristine (Oncovin)}}


[[Etoposide|{{button|E Etoposide}}]]
{{chemo|E|Etoposide}}


[[Prednisone|{{button|P Prednisone}}]]
{{chemo|P|Prednisone}}


==Indications==
==Indications==

Revision as of 15:13, 11 March 2015

WikiDoc Resources for CHOEP regimen

Articles

Most recent articles on CHOEP regimen

Most cited articles on CHOEP regimen

Review articles on CHOEP regimen

Articles on CHOEP regimen in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on CHOEP regimen

Images of CHOEP regimen

Photos of CHOEP regimen

Podcasts & MP3s on CHOEP regimen

Videos on CHOEP regimen

Evidence Based Medicine

Cochrane Collaboration on CHOEP regimen

Bandolier on CHOEP regimen

TRIP on CHOEP regimen

Clinical Trials

Ongoing Trials on CHOEP regimen at Clinical Trials.gov

Trial results on CHOEP regimen

Clinical Trials on CHOEP regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on CHOEP regimen

NICE Guidance on CHOEP regimen

NHS PRODIGY Guidance

FDA on CHOEP regimen

CDC on CHOEP regimen

Books

Books on CHOEP regimen

News

CHOEP regimen in the news

Be alerted to news on CHOEP regimen

News trends on CHOEP regimen

Commentary

Blogs on CHOEP regimen

Definitions

Definitions of CHOEP regimen

Patient Resources / Community

Patient resources on CHOEP regimen

Discussion groups on CHOEP regimen

Patient Handouts on CHOEP regimen

Directions to Hospitals Treating CHOEP regimen

Risk calculators and risk factors for CHOEP regimen

Healthcare Provider Resources

Symptoms of CHOEP regimen

Causes & Risk Factors for CHOEP regimen

Diagnostic studies for CHOEP regimen

Treatment of CHOEP regimen

Continuing Medical Education (CME)

CME Programs on CHOEP regimen

International

CHOEP regimen en Espanol

CHOEP regimen en Francais

Business

CHOEP regimen in the Marketplace

Patents on CHOEP regimen

Experimental / Informatics

List of terms related to CHOEP regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords: CHOPE; VACOP

Overview

CHOEP regimen refers to an immunochemotherapy regimen consisting of cyclophosphamide, Doxorubicin(hydroxydaunorubicin), Vincristine (Oncovin), Prednisone, Etoposide of non-Hodgkin lymphoma.[1][2]

Regimen

CCyclophosphamide

HDoxorubicin (Hydroxydaunomycin)

OVincristine (Oncovin)

EEtoposide

PPrednisone

Indications

References

  1. "NCI Thesaurus".
  2. "R-CHOP - National Cancer Institute".
  3. Pfreundschuh M, Trümper L, Kloess M, Schmits R, Feller AC, Rudolph C; et al. (2004). "Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL". Blood. 104 (3): 626–33. doi:10.1182/blood-2003-06-2094. PMID 14982884.